| Identification | Back Directory | [Name]
1H-Indazole-3-carboxylic acid, 1-(cyclohexylmethyl)-, 1-(methoxycarbonyl)-2,2-dimethylpropyl ester | [CAS]
2365471-04-9 | [Synonyms]
1-methoxy-3,3-dimethyl-1-oxobutan-2-yl1-(cyclohexylmethyl)-1H-indazole-3-carboxylate
1H-Indazole-3-carboxylic acid, 1-(cyclohexylmethyl)-, 1-(methoxycarbonyl)-2,2-dimethylpropyl ester | [Molecular Formula]
C22H30N2O4 | [MOL File]
2365471-04-9.mol | [Molecular Weight]
386.48 |
| Chemical Properties | Back Directory | [Boiling point ]
522.4±30.0 °C(Predicted) | [density ]
1.18±0.1 g/cm3(Predicted) | [solubility ]
DMF: 20 mg/ml; DMSO: 5 mg/ml; Ethanol: 20 mg/ml; Methanol: 1 mg/ml | [form ]
A crystalline solid | [pka]
-1.14±0.50(Predicted) |
| Hazard Information | Back Directory | [Description]
AB-CHMINACA (Item No. 15434) is an indazole-based synthetic cannabinoid (CB) that is structurally related to AB-FUBINACA (Item No. 14039), a high affinity ligand of the CB1 receptor (Ki = 0.9 nM).1,2 MO-CHMINACA is structurally similar to AB-CHMINACA by bearing an identical methylcyclohexyl group; however, the carboxamide-linked aminocarbonyl-2-methylpropyl side chain is substituted with an ester-linked 3,3-dimethylbutyl methyl ester. The physiological and toxicological properties of this compound are not known. This product is intended for forensic and research applications.WARNING This product is not for human or veterinary use. |
|
|